ArticleVeterinary medicine and science2025
In Vitro Investigation of Perfluorooctane Sulphonate and Perfluorooctanoic Acid on Boar Spermatozoa Agglutination.
Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Various toxic agents are associated with male infertility, including perfluoroalkyl substances (PFAS), which are emerging as significant contributors due to their physico-chemical properties that exhibit a propensity for bioaccumulation and potentially pose reproductive risks. The aim of this study was to analyse the effects of perfluorooctane sulphonate (PFOS) and perfluorooctanoic acid (PFOA) on boar spermatozoa during capacitation through a focus on agglutinate formation. A second objective was to assess the influence of d-penicillamine (d-Pen) on boar spermatozoa agglutinate prevention. PFOS and PFOA in sublethal concentrations reduced the proportion of spermatozoa that achieved capacitation, PFOS increased to 35% the spermatozoa mortality and both toxic compounds generated an abnormally excessive increase in rosette-type agglutinates that formed non-mobile aggregates (only vibrant), like those that form during physiological capacitation. This increase in agglutinates came at the expense of available free spermatozoa for fertilisation. Treatment with d-Pen, however, significantly reduced rosette formation by PFAS. Further study of the underlying mechanisms revealed that exposure to PFOS and PFOA led to decreased free sulfhydryl (SH) groups on the surface of the spermatozoa, likely due to oxidation caused by the PFAS. Administering d-Pen also reversed this effect, suggesting a possible involvement of S-S bond formation during spermatozoa agglutination. These findings not only shed light on how PFOS and PFOA affect boar spermatozoa capacitation, but also shows the mechanism associated with spermatozoa rosette-type agglutination provoked by PFOS and PFOA. Furthermore, they underscore the need to delve more deeply into the mechanisms that govern agglutinate formation during spermatozoa capacitation physiology to devise improved, targeted therapeutic strategies for male infertility and enhance animal reproduction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.